Why we are losing the obesity battle

Health issue is costly and the scientific clarity to fight it is lacking

AstraZeneca considers post-Pfizer course

Cooling-off period ends with pressure mounting on CEO Pascal Soriot

NHS trust woes set to boost private sector

Survey says financial pressures will lead to new business openings

Eine Laborantin sichtet Gewebepräparate mit Tumorproben zunächst mit bloßem Auge. Anschließend durchlaufen die Proben zahlreiche weitere Analysen. --------------------------------------------- A lab technician first inspects tissue samples with the naked eye. The tumor samples then undergo additional analytical tests.

Bayer to use IPO funds to cut debt

German group is also to use proceeds to buy consumer drugs

Innovation that exploits the past

Gambling that a rare flash of genius will generate a new, viable idea is expensive

Minister races to boost medicines

Aim is to accelerate innovation while lowering costs for industry

Marley and the birth of Big Weed

The African Herbsman was willing to compromise in return for market reach, writes Jonathan Guthrie

DHDFN2 London, UK. 7th November 2013. a 3D printed implant by Andrew Darwood on display at the 3D Printshow at the Business Design Centre in London. Eric Moger had a large part of his face removed after developing a tumour. © Piero Cruciatti/Alamy Live News

Surgeons embrace 3D printed implants

Advances mean technology has bigger role to play in healthcare

‘Generic guy’ built up to Allergan deal

Bisaro surprised board with proposal to buy Botox maker

Sanofi chairman lays bare tensions

French drugmaker predicts surge in drug launches

Push to inject urgency in drug innovation

Industry and ministers look to boost access to new medication

Obesity: $2tn strain on economy

Costs are similar to those of war or smoking – and are growing

Economic toll of Ebola lower than feared

Lower estimate attributed to success of containment measures

Ranbaxy sues FDA for revoking approvals

Drugmaker appeals decision to scrap US rights for two generics

India’s bad-drug crisis in spotlight

Authorities believe sterilisation deaths caused by tainted medicine

AstraZeneca details standalone strategy

UK-based drugmaker has ‘strengthened’ product pipeline

Allergan seals $66bn deal with Actavis

Merger marks largest healthcare takeover of the year

Actavis-Allergan deal

Blockbuster agreement provides window into pharma

Actavis/Allergan: spoiler alert

Actavis has ruined the most interesting M&A situation in years

Allergan takeover about more than price

$66bn offer for Botox maker a fight for soul of modern pharmaceuticals

EDITOR’S CHOICE

Special report

insulin vials ©Jacob Ehrbahn Combating Diabetes

Special report

An elderly man uses a magnifier to see the descriptions on a pack of medicine at a pharmacy in Dandong, Liaoning province March 30, 2011 ©Jacky Chen/Reuter Health: Emerging Markets

COMPANIES NEWS ON TWITTER

More FT Twitter accounts
SHARE THIS QUOTE